These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8588125)

  • 1. Characterization of B-cell lines from SLE patients and their relatives.
    Witte T; Hartung K; Bode FM; Schmidt RE; Deicher H
    Rheumatol Int; 1995; 15(3):89-93. PubMed ID: 8588125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway.
    Hiramatsu M; Tsokos GC
    Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a monoclonal antibody to a membrane antigen of human T-cell leukaemia virus (HTLV1/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serological analyses for HTLV1 infections in SLE patients.
    Kurata A; Katamine S; Fukuda T; Mine M; Ikari N; Kanazawa H; Matsunaga M; Eguchi K; Nagataki S
    Clin Exp Immunol; 1985 Oct; 62(1):65-74. PubMed ID: 2998659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood.
    Moon UY; Park SJ; Oh ST; Kim WU; Park SH; Lee SH; Cho CS; Kim HY; Lee WK; Lee SK
    Arthritis Res Ther; 2004; 6(4):R295-302. PubMed ID: 15225364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis.
    Tateishi M; Saito I; Yamamoto K; Miyasaka N
    Arthritis Rheum; 1993 Jun; 36(6):827-35. PubMed ID: 8389553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus.
    Sakane T; Suzuki N; Takada S; Ueda Y; Murakawa Y; Tsuchida T; Yamauchi Y; Kishimoto T
    Arthritis Rheum; 1988 Jan; 31(1):80-7. PubMed ID: 3257876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.
    Draborg AH; Sandhu N; Larsen N; Lisander Larsen J; Jacobsen S; Houen G
    J Immunol Res; 2016; 2016():6473204. PubMed ID: 27110576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.
    Kitagawa H; Iho S; Yokochi T; Hoshino T
    Immunol Lett; 1988 Mar; 17(3):249-52. PubMed ID: 2836302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs).
    Wroblewski JM; Copple A; Batson LP; Landers CD; Yannelli JR
    J Immunol Methods; 2002 Jun; 264(1-2):19-28. PubMed ID: 12191505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
    Nagy N
    Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines.
    Kobayashi S; Imajoh-Ohmi S; Kuribayashi F; Nunoi H; Nakamura M; Kanegasaki S
    J Biochem; 1995 Apr; 117(4):758-65. PubMed ID: 7592536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells.
    Suenaga R; Evans MJ; Mitamura K; Rider V; Abdou NI
    J Rheumatol; 1998 Jul; 25(7):1305-12. PubMed ID: 9676761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus.
    van Es JH; Gmelig Meyling FH; van de Akker WR; Aanstoot H; Derksen RH; Logtenberg T
    J Exp Med; 1991 Feb; 173(2):461-70. PubMed ID: 1899104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A factor activating complement via the alternative pathway in the supernatants of B cell lines transformed by Epstein-Barr virus and in sera obtained from patients with systemic lupus erythematosus.
    Hiramatsu M; Tsokos GC
    Int Arch Allergy Appl Immunol; 1988; 86(2):209-14. PubMed ID: 2839425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
    Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
    J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.